Acute myeloblastic leukemia in elderly patients. Treatment and prognostic factors
作者： Josy Reiffers , François Raynal , Antoine Broustet
DOI: 10.1002/1097-0142(19800601)45:11<2816::AID-CNCR2820451117>3.0.CO;2-Q
关键词:
摘要: The results of treatment acute myeloblastic leukemia in patients over 60 years age are evaluated a retrospective study 29 previously untreated patients. These were very similar to those observed for younger patients, with 18 complete remissions (62, 1%), 6 early deaths, and 5 failures. median survival time was seven one half months all 22 the achieving remissions. Nineteen received chemotherapy identical that (daunorubicin cytarabine). initial presence poor prognostic factors (hyperleukocytosis, infection) may explain relativity high number deaths (21%). Elderly apparently not exposed higher risk death than Daunorubicin toxicity does appear increase this agent therefore be used older
sci-hub.se 参考文章(21)
Daniel D. Von Hoff, Marcel Rozencweig, Maxwell Layard, Milan Slavik, Franco M. Muggia, Daunomycin-induced cardiotoxicity in children and adults The American Journal of Medicine. ,vol. 62, pp. 200- 208 ,(1977) , 10.1016/0002-9343(77)90315-1
D. Crowther, C. J. T. Bateman, C. P. Vartan, J. M. A. Whitehouse, J. S. Malpas, G. H. Fairley, R. B. Scott, Combination Chemotherapy using L-Asparaginase, Daunorubicin, and Cytosine Arabinoside in Adults with Acute Myelogenous Leukaemia BMJ. ,vol. 4, pp. 513- 517 ,(1970) , 10.1136/BMJ.4.5734.513
Emil J. Freireich, Louis B. Thomas, Emil Frei, Richard D. Fritz, Claude E. Forkner, A distinctive type of intracerebral hemorrhage associated with "blastic crisis" in patients with leukemia. Cancer. ,vol. 13, pp. 146- 154 ,(1960) , 10.1002/1097-0142(196001/02)13:1<146::AID-CNCR2820130126>3.0.CO;2-1
Marc J. Gurwith, James L. Brunton, Beverley A. Lank, Allan R. Ronald, Godfrey K.M. Harding, Granulocytopenia in hospitalized patients The American Journal of Medicine. ,vol. 64, pp. 121- 126 ,(1978) , 10.1016/0002-9343(78)90187-0
Bruce A. Peterson, Clara D. Bloomfield, Treatment of acute nonlymphocytic leukemia in elderly patients.A prospective study of intensive chemotherapy Cancer. ,vol. 40, pp. 647- 652 ,(1977) , 10.1002/1097-0142(197708)40:2<647::AID-CNCR2820400209>3.0.CO;2-5
J.K.H. Rees, F.G.J. Hayhoe, D.A.T. (daunorubicin, cytarabine, 6-thioguanine) in acute myeloid leukaemia. The Lancet. ,vol. 311, pp. 1360- 1361 ,(1978) , 10.1016/S0140-6736(78)92433-9
Victorio Rodriguez, Jacqueline S. Hart, Emil J. Freireich, Gerald P. Bodey, Kenneth B. McCredie, John P. Whitecar, Charles A. Coltman, POMP combination chemotherapy of adult acute leukemia Cancer. ,vol. 32, pp. 69- 75 ,(1973) , 10.1002/1097-0142(197307)32:1<69::AID-CNCR2820320109>3.0.CO;2-0
Bayard D. Clarkson, Monroe D. Dowling, Timothy S. Gee, Isabel B. Cunningham, Joseph H. Burchenal, Treatment of acute leukemia in adults Cancer. ,vol. 36, pp. 775- 795 ,(1975) , 10.1002/1097-0142(197508)36:2+<775::AID-CNCR2820360824>3.0.CO;2-V
Clara D Bloomfield, Athanasios Theologides, Acute Granulocytic Leukemia in Elderly Patients JAMA: The Journal of the American Medical Association. ,vol. 226, pp. 1190- 1193 ,(1973) , 10.1001/JAMA.1973.03230100022007
William Greene, David Huffman, Peter H. Wiernik, Stephen Schimpff, Robert Benjamin, Nicholas Bachur, High-dose daunorubicin therapy for acute nonlymphocytic leukemia: Correlation of response and toxicity with pharmacokinetics and intracellular daunorubicin reductase activity Cancer. ,vol. 30, pp. 1419- 1427 ,(1972) , 10.1002/1097-0142(197212)30:6<1419::AID-CNCR2820300602>3.0.CO;2-I